Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.
This study has been completed.
First Posted: February 24, 2011
Last Update Posted: November 22, 2016
Association Française contre les Myopathies (AFM), Paris
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||October 2013|
|Primary Completion Date:||October 2013 (Final data collection date for primary outcome measure)|